intracerebral%20hemorrhage
INTRACEREBRAL HEMORRHAGE
Intracerebral hemorrhage is the sudden burst of blood into the brain tissue itself.
It causes sudden onset of focal neurological deficit.
The focal neurologic findings are related to the anatomic location, size and speed of development of intracerebral hemorrhage.
Neurological deficit usually progresses over a minute to an hour.
Rapid recognition and diagnosis of intracerebral hemorrhage are essential because of its frequently rapid progression.

Surgical Intervention

  • The usefulness of surgical therapy, in most patients with intracerebral hemorrhage (ICH), remains controversial
    • Surgery may limit mechanical compression and neurotoxic effects of blood but surgical risks in a bleeding patient may be greater
  • Minimally invasive procedures including stereotactic- or endoscopic-guided evacuation with or without thrombolysis is considered investigational
  • Very early craniotomy may increase the risk of recurrent bleeding
  • For patients with hydrocephalus with decreased level of consciousness, ventricular drainage may be a reasonable option
  • Ventricular drainage alone rather than surgical evacuation is not recommended

Surgical Candidates

  • Cerebellar hemorrhage >3 cm with the following:
    • Neurological deterioration or
    • Brain stem compression and/or hydrocephalus from ventricular obstruction
  • Lobar clots >30 mL & within 1 cm of the surface
  • Intracerebral hemorrhage with mass effect lesion if surgically accessible and patient has chance of good outcome
  • Young patients with moderate-large lobar hemorrhage and who are deteriorating clinically
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Tristan Manalac, 09 Sep 2018
Structured and remote patient management interventions are effective in reducing all-cause mortality and the number of days lost due to unplanned hospitalizations in heart failure patients, according to a recent study.
Radha Chitale, 08 Apr 2016
A trial assessing the implantable CardioFit® device designed to stimulate the parasympathetic nervous system in heart failure patients failed to meet its primary endpoints – reducing the rate of hospitalization due to heart failure or death by any cause.
27 Aug 2018
Obese men appear to have better ST-elevation myocardial infarction (STEMI) prognoses than their normal weight counterparts, regardless of metabolic syndrome status, a recent study has shown.
27 Jul 2018
There appears to be no association between intraduodenal administration of the artificial sweetener sucralose in healthy older patients and changes in blood pressure (BP) or superior mesenteric artery (SMA) blood flow, reports a study.